Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

Kim Hørslev-Petersen; Merete Lund Hetland; Peter Junker; Jan Pødenphanth; Torkell Ellingsen; Palle Ahlqvist; Hanne M. Lindegaard; Asta Linauskas; Annette Schlemmer; Mette Y. Dam; Ib Hansen; Hans Chr. Horn; Anette Jørgensen; Sophine Boysen Krintel; Johnny Raun; Christian G. Ammizbøll; Julia Sidenius Johansen; Mikkel Østergaard; Kristian Stengaard-Pedersen

Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

Kim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, Jan Pødenphanth, Torkell Ellingsen, Palle Ahlqvist, Hanne M. Lindegaard, Asta Linauskas, Annette Schlemmer, Mette Y. Dam, Ib Hansen, Hans Chr. Horn, Anette Jørgensen, Sophine Boysen Krintel, Johnny Raun, Christian G. Ammizbøll, Julia Sidenius Johansen, Mikkel Østergaard, Kristian Stengaard-Pedersen

Abstract

Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

Original language	English
Journal	Arthritis & Rheumatism
Volume	63
Issue number	10 (suppl.)
Pages (from-to)	S147
Number of pages	1
ISSN	0004-3591
Publication status	Published - 2011

Fingerprint

Dive into the research topics of 'Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.'. Together they form a unique fingerprint.

Cite this

Hørslev-Petersen, K., Hetland, M. L., Junker, P., Pødenphanth, J., Ellingsen, T., Ahlqvist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Jørgensen, A., Krintel, S. B., Raun, J., Ammizbøll, C. G., Johansen, J. S., Østergaard, M., & Stengaard-Pedersen, K. (2011). Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study. Arthritis & Rheumatism, 63(10 (suppl.)), S147.

Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study. / Hørslev-Petersen, Kim; Hetland, Merete Lund; Junker, Peter et al.

In: Arthritis & Rheumatism, Vol. 63, No. 10 (suppl.), 2011, p. S147.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Hørslev-Petersen, K, Hetland, ML, Junker, P, Pødenphanth, J, Ellingsen, T, Ahlqvist, P, Lindegaard, HM, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Horn, HC, Jørgensen, A, Krintel, SB, Raun, J, Ammizbøll, CG, Johansen, JS , Østergaard, M & Stengaard-Pedersen, K 2011, 'Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.', Arthritis & Rheumatism, vol. 63, no. 10 (suppl.), pp. S147.

Hørslev-Petersen K, Hetland ML, Junker P, Pødenphanth J, Ellingsen T, Ahlqvist P et al. Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study. Arthritis & Rheumatism. 2011;63(10 (suppl.)):S147.

Hørslev-Petersen, Kim ; Hetland, Merete Lund ; Junker, Peter et al. / Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study. In: Arthritis & Rheumatism. 2011 ; Vol. 63, No. 10 (suppl.). pp. S147.

@article{cef935d1db23436693eda34e0f5392da,

title = "Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-na{\"i}ve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.",

abstract = "Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-na{\"i}ve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.",

author = "Kim H{\o}rslev-Petersen and Hetland, {Merete Lund} and Peter Junker and Jan P{\o}denphanth and Torkell Ellingsen and Palle Ahlqvist and Lindegaard, {Hanne M.} and Asta Linauskas and Annette Schlemmer and Dam, {Mette Y.} and Ib Hansen and Horn, {Hans Chr.} and Anette J{\o}rgensen and Krintel, {Sophine Boysen} and Johnny Raun and Ammizb{\o}ll, {Christian G.} and Johansen, {Julia Sidenius} and Mikkel {\O}stergaard and Kristian Stengaard-Pedersen",

year = "2011",

language = "English",

volume = "63",

pages = "S147",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "10 (suppl.)",

}

TY - ABST

T1 - Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Junker, Peter

AU - Pødenphanth, Jan

AU - Ellingsen, Torkell

AU - Ahlqvist, Palle

AU - Lindegaard, Hanne M.

AU - Linauskas, Asta

AU - Schlemmer, Annette

AU - Dam, Mette Y.

AU - Hansen, Ib

AU - Horn, Hans Chr.

AU - Jørgensen, Anette

AU - Krintel, Sophine Boysen

AU - Raun, Johnny

AU - Ammizbøll, Christian G.

AU - Johansen, Julia Sidenius

AU - Østergaard, Mikkel

AU - Stengaard-Pedersen, Kristian

PY - 2011

Y1 - 2011

N2 - Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

AB - Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

M3 - Conference abstract in journal

SN - 2326-5205

VL - 63

SP - S147

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 10 (suppl.)

ER -